Canterbury DHB

Context

Monitoring of Treatment

Adequacy of treatment is determined by appropriate treatment of symptoms. If flushing, sweating and other estrogen deficiency symptoms continue to occur then the dose of oestrogen may need to be increased. It is not useful to check FSH levels as these may remain elevated despite adequate doses of estrogen. Likewise many of the forms of estrogen (e.g. Premarin) do not alter blood estradiol levels and measuring this can be misleading.

About this Canterbury DHB document (22134):

Document Owner:

Not assigned (see Who's Who)

Issue Date:

January 2019

Next Review:

January 2022

Keywords:

Note: Only the electronic version is controlled. Once printed, this is no longer a controlled document. Disclaimer

Topic Code: 22134